Twist Bioscience Corp diskutieren
Twist Bioscience Corp
WKN: A2N7L2 / Symbol: TWST / Name: Twist Bioscience / Aktie / Pharmazeutika / Small Cap /
30,37 €
3,32 %
Twist Bioscience Co. (NASDAQ: TWST) had its "outperform" rating re-affirmed by analysts at Scotiabank.
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) had its price target lowered by analysts at Barclays PLC from $58.00 to $45.00. They now have an "overweight" rating on the stock.
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) had its price target lowered by analysts at Robert W. Baird from $54.00 to $44.00. They now have an "outperform" rating on the stock.
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) had its price target lowered by analysts at JPMorgan Chase & Co. from $40.00 to $33.00. They now have an "underweight" rating on the stock.
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $50.00 price target on the stock.
Ratings data for TWST provided by MarketBeat
Twist Bioscience Co. (NASDAQ: TWST) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $55.00 to $48.00. They now have a "buy" rating on the stock.
Ratings data for TWST provided by MarketBeat
Der Beitrag wird untersucht
Twist Bioscience (NASDAQ:TWST) had its price target lowered by analysts at Evercore ISI from $46.00 to $42.00. They now have an "outperform" rating on the stock.
Ratings data for TWST provided by MarketBeat
Twist Bioscience (NASDAQ:TWST) had its price target lowered by analysts at Barclays PLC from $40.00 to $37.00. They now have an "overweight" rating on the stock.
Ratings data for TWST provided by MarketBeat
Twist Bioscience (NASDAQ:TWST) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Ratings data for TWST provided by MarketBeat
Twist Bioscience (NASDAQ:TWST) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Ratings data for TWST provided by MarketBeat
Twist Bioscience (NASDAQ:TWST) had its price target raised by analysts at TD Cowen from $32.00 to $43.00. They now have a "buy" rating on the stock.
Ratings data for TWST provided by MarketBeat
Neueste Beiträge
StockNews_com in Mersana Therapeutics diskutieren